Stock Market News

Hafnia announces $0.379 quarterly dividend

Hafnia Limited (NYSE: HAFN) said on Wednesday that its Board of Directors had authorized a regular quarterly cash dividend of $0.379 per share of common stock. The dividend was kept unchanged from the previous quarterly dividend payment. The dividend will be paid on December 12th to shareholders of record as of the close of business […] Read more

TOYO awarded $150 mln solar cell supply contract, shares soar 86%

TOYO Co. Ltd (NASDAQ: TOYO), a solar solution company, said on Tuesday that it had secured a $150 million contract to supply high efficiency solar cells to a leading solar module manufacturer. Under the agreement, TOYO is to supply its cutting-edge solar cells to support the client’s expanding solar module production in both India and […] Read more

US Bancorp upgraded to “Buy” at Citigroup

Citigroup has upgraded US Bancorp (NYSE: USB) to “Buy” from “Neutral”. Citi also raised its 12-month price target on the stock to $65.00 from $49.00 previously. According to Citigroup, US Bancorp has “turned the corner” on investment spend and is expected to return to positive operating leverage as expense growth moderates. Also, US Bancorp’s net […] Read more

Scholar Rock shares surge 26% as rival Biohaven misses SMA study goal

The shares of Scholar Rock Holding Corp (NASDAQ: SRRK) soared 26.07% on Monday, after an experimental, muscle-preserving drug by competitor Biohaven missed its goal in a Phase 3 study of people suffering from spinal muscular atrophy (SMA). taldefgrobep alfa, a regimen of Biohaven’s drug, and a standard SMA therapy failed to significantly improve motor function […] Read more

DURECT Corp sells ALZET product line to Lafayette

DURECT Corporation (NASDAQ: DRRX) said on Monday that it had sold its ALZET line of osmotic pumps to Lafayette Instrument Co in a deal valued at $17.5 million. The company also said it had paid off all remaining obligations under the term loan agreement with Oxford Finance LLC. “As DURECT continues to prioritize developing larsucosterol […] Read more

Wolfe Research upgrades Jones Lang Lasalle to “Outperform”

Wolfe Research has upgraded Jones Lang Lasalle Inc (NYSE: JLL) to “Outperform” from “Peer Perform”, while assigning a 12-month price target of $353.00 on the stock. According to Wolfe Research, Jones Lang Lasalle benefits from capital markets comps and improved disclosure supports multiple expansion. Meanwhile, sector tailwinds from potential deregulation and tax reform may speed […] Read more